Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Antares Pharma
(NQ:
ATRS
)
4.100
USD
-0.020 (-0.49%)
Official Closing Price
Updated: 4:26 PM EDT, Apr 9, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Antares Pharma
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
First Week of November 19th Options Trading For Antares Pharma (ATRS)
March 19, 2021
Investors in Antares Pharma Inc. (ATRS) saw new options begin trading this week, for the November 19th expiration..
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
March 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Biotech
LHDX
ATRS
From
Benzinga
Recap: Antares Pharma Q4 Earnings
March 02, 2021
Shares of Antares Pharma (NASDAQ:ATRS) were unchanged after the company reported Q4 results. Quarterly Results Earnings ...
Tags
Market News
BZI/Recaps
News
From
Benzinga
Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results
March 02, 2021
From
GlobeNewswire News Releases
Earnings Scheduled For March 2, 2021
March 02, 2021
Companies Reporting Before The Bell • Kopin (NASDAQ:KOPN) is expected to report quarterly loss at $0.01 per share on ...
Tags
HRZN
KSS
Earnings
From
Benzinga
Analysts Forecast 10% Upside For The Holdings of XHE
March 01, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Antares Pharma's Earnings: A Preview
March 01, 2021
Antares Pharma (NASDAQ:ATRS) releases its next round of earnings this Tuesday, March 02. Get the latest predictions in Benzinga's ...
Tags
Market News
Earnings
Benzinga
From
Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
February 27, 2021
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ...
Tags
BHVN
MRK
BNTX
From
Benzinga
Antares Pharma to Present at Two Upcoming Investor Conferences
February 24, 2021
From
GlobeNewswire News Releases
Antares Pharma to Report Fourth Quarter and Full-Year 2020 Financial and Operating Results
February 23, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
February 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ENDP
INSM
CLPT
From
Benzinga
Antares Pharma to Participate in the SVB Leerink 10th Annual Virtual Global Healthcare Conference
February 17, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
February 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ITCI
EDAP
VERU
From
Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FDA
ALNY
SIBN
From
Benzinga
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
January 11, 2021
Company updates full-year 2020 revenue guidance to $145-150 million
From
GlobeNewswire News Releases
3 Top Stocks Trading Under $5 a Share
December 25, 2020
These interesting low-cost stocks have the opportunity to grow.
Tags
Market News
FLNT
OPK
From
Motley Fool
3 Top Stocks Under $5
November 28, 2020
These companies offer more potential than the stock price might indicate.
Tags
NOK
Market News
AMD
From
Motley Fool
Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 23, 2020
From
GlobeNewswire News Releases
Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference
November 10, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
MYOK
CLVS
ONCR
From
Benzinga
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
November 05, 2020
From
GlobeNewswire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ...
Tags
CNCE
BMY
PRVB
From
Benzinga
Analysts See 28% Gains Ahead For RYJ
October 27, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Antares Pharma to Report Third Quarter 2020 Financial and Operating Results
October 22, 2020
From
GlobeNewswire News Releases
4 Penny Stocks To Buy According To Analysts; 1 With A 189% Target
October 01, 2020
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.
October 01, 2020
Antares Expands Urology Portfolio and Leverages Commercial Organization
From
GlobeNewswire News Releases
Add Up The Parts: VHT Could Be Worth $231
September 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
First Week of ATRS May 2021 Options Trading
September 22, 2020
Investors in Antares Pharma Inc. (ATRS) saw new options begin trading this week, for the May 2021 expiration..
Tags
Stocks
From
Market News Video
Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference
September 08, 2020
From
GlobeNewswire News Releases
Analysts Forecast 13% Upside For ESML
August 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.